Tindamax FDA Approval History
FDA Approved: Yes (First approved May 17, 2004)
Brand name: Tindamax
Generic name: tinidazole
Dosage form: Tablets
Company: Presutti Laboratories
Treatment for: Trichomoniasis, Giardiasis, Bacterial Vaginosis
Tindamax (tinidazole) is a synthetic nitroimidazole antiprotozoal agent for the treatment of trichomoniasis, giardiasis, amebiasis, and bacterial vaginosis in nonpregnant women.
Development timeline for Tindamax
Date | Article |
---|---|
May 24, 2007 | Approval FDA Approves Tindamax for Bacterial Vaginosis |
May 17, 2004 | Approval Tindamax Presutti Laboratories - Treatment for Infections |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.